PeptidePedia The community reference

Beyond-use date: difference between revisions

Diff·revision 30 → 31·19:02, 18 Mar 2025

Difference between revision 30 and revision 31 of Beyond-use date. 8 lines changed; the page grew by 1,001 bytes.

Revision 30 — 06:59, 12 Mar 2025
StabilityStig (talk)
rm unsourced claim per PP:V
11,093 bytes ±0
Revision 31 — 19:02, 18 Mar 2025
SyringeSybille (talk)
ce
12,094 bytes +1,001
81The 2023 chapter also permits longer dating where supported by a stability-indicating study on the preparation, or by published stability information for the same formulation in the same container and storage condition. The qualification about container and condition is not incidental: published stability data for a solution in a glass vial does not transfer to the same solution in a plastic syringe, because sorption and permeation differ.{{r|usp795,trissel2022}}81The 2023 chapter also permits longer dating where supported by a stability-indicating study on the preparation, or by published stability information for the same formulation in the same container and storage condition. The qualification about container and condition is not incidental: published stability data for a solution in a glass vial does not transfer to the same solution in a plastic syringe, because sorption and permeation differ.{{r|usp795,trissel2022}}
8282
+83== Opened containers ==
+84Entering a container ends the applicability of its expiration date, because the container closure system on which that date depended has been breached. Dating from that point follows the rules described at [[Multi-dose vial|multiple-dose containers]] and summarised here.
+85
+86; Single-dose containers : Entered in ISO Class 5 air or better, usable for up to 12 hours; entered in poorer air, up to 1 hour. The dependence on air quality reflects that the risk is airborne and personnel-borne contamination at the moment of entry.
+87; Multiple-dose containers : 28 days after initial puncture, unless the manufacturer specifies a shorter period. The preservative, not the environment, is what permits the longer period.
+88; Pharmacy bulk packages : As stated on the label, conventionally a small number of hours after entry.{{r|usp797,usp659}}
+89
83== References ==90== References ==
84{{reflist}}91{{reflist}}
85<ref name="usp797">United States Pharmacopeia, General Chapter <797>, "Pharmaceutical Compounding — Sterile Preparations", 2023 revision, including the beyond-use date tables for Category 1, 2 and 3 preparations.</ref>92<ref name="usp797">United States Pharmacopeia, General Chapter <797>, "Pharmaceutical Compounding — Sterile Preparations", 2023 revision, including the beyond-use date tables for Category 1, 2 and 3 preparations.</ref>
86<ref name="usp795">United States Pharmacopeia, General Chapter <795>, "Pharmaceutical Compounding — Nonsterile Preparations", 2023 revision.</ref>93<ref name="usp795">United States Pharmacopeia, General Chapter <795>, "Pharmaceutical Compounding — Nonsterile Preparations", 2023 revision.</ref>
+94<ref name="usp659">United States Pharmacopeia, General Chapter <659>, "Packaging and Storage Requirements". USP–NF, current revision.</ref>
87<ref name="usp1191">United States Pharmacopeia, General Chapter <1191>, "Stability Considerations in Dispensing Practice" (informational). USP–NF, current revision.</ref>95<ref name="usp1191">United States Pharmacopeia, General Chapter <1191>, "Stability Considerations in Dispensing Practice" (informational). USP–NF, current revision.</ref>
88<ref name="ich_q1a">International Council for Harmonisation, ''Q1A(R2): Stability Testing of New Drug Substances and Products'' (2003), read with ''Q1E: Evaluation for Stability Data'' (2003).</ref>96<ref name="ich_q1a">International Council for Harmonisation, ''Q1A(R2): Stability Testing of New Drug Substances and Products'' (2003), read with ''Q1E: Evaluation for Stability Data'' (2003).</ref>